This document is an outcome of a process to establish a regional framework defining the key elements of a comprehensive response to HIV among MSM and transgender persons (TGs) in the Asia Pacific Region.
This document summarizes the discussions and most relevant recommendations made during a meeting of experts that immediately followed the Experts Consultation on Comprehensive Sexuality Education in Mexico City on 1-2 September, 2009.
This powerpoint is an address given on African Universities responding to HIV and AIDS at Uganda Martyrs' University, in February 2009.
This report presents the key points and recommendations that emerged over the course of a two-day international technical consultation on positive prevention held in Hammamet, Tunisia on 27-28 April 2009.
The meeting report 1) describes the priority health sector interventions recommended to achieve universal access for the prevention, treatment, care and support of HIV and sexually transmitted infections among MSM within the broader male sexual health agenda; 2) summarizes key policy and technica
The National SHN Strategy aims to provide a uniform approach to agencies working in the field of health and nutrition of school children.
Over the past two decades, many governments and organizations have renewed efforts to develop more effective school-based health and nutrition programmes in low income countries.
This paper's main aim is to synthesize recent existing evidence and outline the key messages that will improve understanding of the situation of children affected by HIV and AIDS. It is intended to stimulate a wider dialogue among policymakers, practitioners, researchers and donors.
Project activities focused around the XVII International AIDS Conference (IAC) and a pre-conference symposium on children and HIV, both held in Mexico City from 1-8 August 2008.
Descripción general del trabajo deáreducción de daños asociados a las drogas ilícitas en América Latina al año 2008. También se menciona los problemas causados por alcohol, todo en relación al VIH/SIDA.